2016-05-30-世界卫生组织-Diabetes_China_2016_country_profile_1页_340kb

China Diabetes Profile Summary (WHO 2016)

China's total population stands at 1.376 billion, categorized as an upper-middle-income nation.
Diabetes mortality projections carry high uncertainty, potentially impacting around 319,000 (ages 30+), with significant numbers classified as directly attributable to high blood glucose (ages 30-69).
Key diabetes conditions represent a major cause of death, accounting for 45% of global non-communicable disease burden-related deaths in China, alongside cardiovascular diseases (25%) and cancers (23%).
Diabetes prevalence figures indicate the condition affects about 9.4% of China's population overall. Risk factors are widespread, with 35.4% of people being overweight and 7.3% obese, along with high levels of physical inactivity (23.8%).
While policies and basic diabetes guidelines exist, there is scope for improvement in implementing strategies against overweight/obesity and increasing physical inactivity prevention. China has diabetes registries, surveys measuring blood glucose, and provides fundamental primary care medicines and technologies for diabetes management, though access to more specialized treatments (e.g., retinal photocoagulation, renal transplantation) remains limited.